logo
  • Funds

    Fund Listing

    • Fund Range
    • Fund Documents
    • How to Invest

    Asset Classes

    • Alternatives
    • Equities
    • Fixed Income

    Featured Funds

    • Alternative Investments
    • Fixed Income Funds
    • Global Macro Sustainable Fund
    • Global Macro Opportunities Fund
    • Global Research Enhanced Index (REI) Fund
  • Insights

    Market Insights

    • Guide to the Markets
    • Guide to Alternatives
    • Weekly Market Recap
    • On the Minds of Investors
    • Guide to China
    • Market Insights Overview

    Portfolio Insights

    • Long-Term Capital Market Assumptions
    • Global Asset Allocation Views
    • Global Fixed Income Views
    • Portfolio Insights Overview
  • Investment Ideas
    • Managing Volatility
    • Alternatives
    • Sustainable Investing
  • Resources
    • Multimedia
    • Announcements
    • Insights App
  • About Us
  • Contact Us
Skip to main content
  • Role
  • Country
  • Search
    Search
    Menu
    1. Corporate Fundamentals: The recovery continues

    • LinkedIn Twitter Facebook Line

    Corporate Fundamentals: The recovery continues

    09/09/2021

    Kay Herr

    As widely reported, corporate earnings for the second quarter broadly beat expectations across sectors and regions. Sustained improvement in revenue and EBITDA propelled continued advances in equity indices. Concomitantly, corporate financials continued to improve, as we projected in our blog last quarter. Figure 1 below depicts the marked improvement realized, on a quarter-over-quarter basis, in both US and European investment grade fundamentals.

    Figure 1: Improving fundamentals in US and European Investment Grade companies

    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 12th August, 2021

    While a lot of attention has focused on improvements in year-over-year quarterly revenue and EBITDA, as shown in Figure 1, we thought it would be worthwhile to review the extent to which corporate health has improved versus pre-pandemic levels. We have highlighted previously the marked difference between gross and net leverage, as shown in Figure 2.  Notably, net leverage in US and European investment-grade companies was relatively stable from early 2019 through Q3 2020, but gross leverage continued to rise during that period as companies accessed low-cost capital, conserving much of it on their balance sheets.

    Figure 2: Sustained deltas between gross and net leverage across regions

    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 12th August, 2021

    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 12th August, 2021

    As shown in Figure 3, both investment-grade and high-yield companies have material cash balances, both as a percent of their outstanding debt as well as assets. Cash levels have declined somewhat from recent peaks as companies have begun to increase or reinstate dividends, share repurchases, and capital expenditures, as we had predicted.

    Figure 3: Cash balances remain elevated

    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 12th August, 2021

    As we have written previously, corporations have capitalized on low interest rates, refinancing debt to lower their future interest expense.  Lower interest expense and improving EBITDA have translated into enhanced coverage across investment-grade and high-yield companies in the US as well as European investment-grade companies.  We expect coverage levels, as measured by trailing-twelve-month adjusted EBITDA to interest expense, to continue to improve this year.

    Figure 4: Improving coverage ratios

    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 12th August, 2021

    With the marked improvement in operating fundamentals as well as balance sheet metrics, the rating agencies have reversed course from last year. As shown in Figure 5, the moving average of upgrades versus downgrades is sharply higher in both the investment-grade and high-yield universes.  As we have noted previously, emerging-market leverage levels were not as elevated going into the pandemic as those in developed markets.  Therefore rating agency downgrades were not as swift last year; upgrades in emerging markets have not been as robust either. While we continue to see opportunity for more upgrades, we expect the ratio of upgrades to downgrades to moderate.

    Figure 5: Rating agency upgrades are outpacing downgrades


    Source: ICE BofAML, Bloomberg, GFICC Quantitative Solutions calculations; data as of 27th August, 2021

    As noted above, many companies are focused on reducing leverage; however, others are deploying excess liquidity to enhance shareholder returns.  We note that merger and acquisition activity is rising across sectors.  Notable deals include AerCap acquiring GE Capital, Canadian Pacific buying Kansas City Southern, Discovery acquiring WarnerMedia, and Microsoft purchasing discord. As a result, we continue to see idiosyncratic risk among issuers rising. Bottom-up fundamental research remains critical to successful investing across investment-grade and high-yield sectors.

    Related Content

    Corporate Fundamentals: Living in interesting times

    Despite inflationary headwinds and geopolitical concerns, corporate fundamentals remain healthy.

    Read more

    Central banks are on the move

    Central banks have opted to tighten monetary policy in the face of inflationary pressure causing higher volatility in IG credit markets.

    Read more

    Corporate Fundamentals: Where do we go from here?

    While moderating somewhat over the last quarter, the overall pace of improvement in corporate health in the last eighteen months is nothing short of remarkable. Overall, we expect fundamentals to stabilize in 2022.

    Read more
    • Corporates
    JPMorgan Asset Management

    • Terms & Conditions
    • Financial Services Guide
    • Privacy Policy
    • Cookie Policy
    • Investment Stewardship
    • Voting Policy
    • Unit Pricing Policy
    • Complaint Resolution
    • Sitemap
    J.P. Morgan

    • J.P. Morgan
    • JPMorgan Chase
    • Chase

    © 2022 All Rights Reserved - JPMorgan Asset Management (Australia) Limited   ABN 55 143 832 080, AFSL No. 376919

    The information provided on this website is general in nature only and does not constitute personal financial advice. The information has been prepared without taking into account your personal objectives, financial situation or needs. Before acting on any information on this website you should consider the appropriateness of the information having regard to your objectives, financial situation and needs. Therefore, before you decide to buy any product or keep or cancel a similar product that you already hold, it is important that you read and consider the relevant JPMorgan fund Product Disclosure Statement (PDS) and Target Market Determination, which is available to download on this website and make sure that the product is appropriate for you. Before making any decision, it is important for you to consider these matters and to seek appropriate legal, tax, and other professional advice.